Home > Healthcare > Medical Services > Assisted Reproductive Technology (ART) Market

Assisted Reproductive Technology (ART) Market Size

  • Report ID: GMI506
  • Published Date: May 2024
  • Report Format: PDF

Assisted Reproductive Technology Market Size

Assisted Reproductive Technology Market size was valued at around USD 34.7 billion in 2023 and is estimated to grow at 6.9% CAGR from 2024 to 2032. Assisted reproductive technology refers to a medical treatment procedure that addresses infertility problems. It includes in-vitro fertilization and artificial insemination. Increasing success rates of these procedures has offered more effective care solutions in hospitals, fertility clinics and surgical centers.


The rising prevalence of infertility across the population base serves as a significant driver for the ART market. According to the World Health Organization (WHO), in 2023, around 17.5% of the adult population – roughly 1 in 6 worldwide experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need. Further, as per the same report, lifetime infertility prevalence was 17.8% for high-income countries and 16.5% for low- and middle-income countries. As fertility rates decline globally, individuals and couples are increasingly turning to ART services to overcome infertility challenges and achieve their family-building goals.

Furthermore, increasing shift towards infertility treatment devices, rising adoption of infertility drugs, advancement in mother care products, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the increasing factors nurturing the growth of the market.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Assisted reproductive technology market size was USD 34.7 billion in 2023 and is expected to register 6.9% CAGR from 2024-2032 owing to the rising prevalence of infertility across the population base worldwide.

Assisted reproductive technology industry from the procedure segment is expected to reach USD 58.6 billion by 2032 due to rising prevalence of infertility owing to various factors such as lifestyle changes, environmental factors, and delaying childbirth.

The U.S. assisted reproductive technology industry is expected to register 6.5% CAGR from 2024-2032 due to the increasing percentage of IVF delivery rate/cycle and rising number of patients adopting the ART procedures in the region.

Merck KGaA, MISTRAL FERTILITY CLINICS S.L., NidaCon International AB, Sumitomo Mitsui Financial Group, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific Inc., Vitrolife Group, and Western Fertility Institute, are some of the major assisted reproductive technology companies worldwide.

Assisted Reproductive Technology Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 196
  • Countries covered: 19
  • Pages: 125
 Download Free Sample